Visit TheBody.com for Patient Education
You are not currently logged in.
Login
or
Register
Sign up for free e-mail/fax newsletters!
Now Live:
Breaking Research From XVII International AIDS Conference >>
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy
Antiretroviral Therapy
Acute Infection
Antiretrovirals
Assays (Diagnostic & Monitoring)
Guidelines
Initial Therapy
Pediatrics
Resistance
Salvage Therapy
Second/Third-Line Treatment
Structured Treatment Interruptions
Women & Pregnancy
More ...
Complications of HIV/HAART
Complications of HIV/HAART
Overview
Cardiovascular
Lipoatrophy
Gastrointestinal
Hepatitis
HPV & Cervical/Anal Cancer
Liver Complications
Malignancies
Mental Health
Metabolic
Neurocognitive
Renal Complications
Women-Specific
More ...
Research & Development
Research & Development
Overview
Antiretrovirals in Development
Conference Reports
HIV Genetics
HIV Immunology
More ...
Clinical Trials
Clinical Trials
Overview & News
U.S. Databases
U.S. Nationwide Studies
U.S. State-by-State Trial Listings
Databases Outside U.S.
Specific Trials Outside U.S.
More ...
Quality of Life & Patient Care
Quality of Life & Patient Care
Complementary Medicine
Mental Health
Primary Care
Maturation Inhibitors in Development
A Clinical Overview of PA-457
(Regularly Updated)
To read PDF,
click here
From
U.S. National Institutes of Health
Maturation Inhibitors in Development
(March 30, 2006)
An overview from Edwin DeJesus, M.D.
From
The Body
Phase IIa Trial of Maturation Inhibitor PA-457 Shows Up to 90% Reduction in HIV Viral Load
(August 24, 2005)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation